Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Philip Rosenthal

Pediatrics San Francisco, CA Medical Doctor

NPI 1417066242 CMS profile 18654

500 Parnassus Mu 4Th Fl E, San Francisco, CA 94143

Open in the dashboard

General payments

$81,964

84 records reported · program years 2019–2025

Research payments

$6,410

Paid to them · 24 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,100,291 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Philip Rosenthal of San Francisco, CA is reported in the CMS Open Payments database as having received $81,964 across 84 general payments and $6,410 in research payments paid to them. Separately, studies naming them as principal investigator received $1,100,291 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $22,681 20
2025 Research $4,200 5
2024 General $8,274 19
2023 General $13,024 14
2023 Research $2,065 17
2022 General $33,886 25
2021 General $3,345 4
2020 General $753 2
2019 Research $145 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Philip Rosenthal
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Philip Rosenthal were reported at $22,681. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Philip Rosenthal Pediatrics median Middle half National median
2019 $0 $86 $31–$183 $163
2020 $753 $49 $22–$110 $114
2021 $3,345 $68 $27–$158 $132
2022 $33,886 $77 $30–$173 $149
2023 $13,024 $88 $33–$190 $160
2024 $8,274 $94 $34–$206 $164
2025 $22,681 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Mirum Pharmaceuticals, Inc. $52,138 51 payments
  2. Ipsen Biopharmaceuticals, Inc $15,668 8 payments
  3. Albireo Pharma, Inc. $4,599 3 payments
  4. Gilead Sciences, Inc. $2,744 2 payments
  5. Takeda Pharmaceuticals U.S.A., Inc. $2,159 12 payments
  6. BioMarin Pharmaceutical Inc. $1,800 1 payment
  7. Vertex Pharmaceuticals Incorporated $1,400 2 payments
  8. Cepheid $503 1 payment
  9. ZOLL Medical Corporation $358 1 payment
  10. Intra-Sana Laboratories $250 1 payment
  11. Other $345 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $49,011 27 payments
  2. Travel and Lodging $14,629 21 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $13,505 3 payments
  4. Honoraria $2,740 2 payments
  5. Food and Beverage $2,079 31 payments
Products named General payments · program years 2019–2025
  1. Livmarli $39,657 40 payments
  2. Bylvay $20,207 10 payments
  3. Vemlidy $2,710 1 payment
  4. GENEXPERT $503 1 payment
  5. RELTONE 200 MG $250 1 payment
  6. RELTONE 400 MG $250 1 payment
  7. VARIAX $145 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. AbbVie, Inc. $4,200 5 payments
  2. Takeda Pharmaceuticals U.S.A., Inc. $2,065 17 payments
  3. Gilead Sciences, Inc. $145 2 payments

Records

108 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record